Biocon Biologics and Yoshindo expand access to Ustekinumab Biosimilar in Japan

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced th...

May 21, 2025 | Wednesday | News
Japanese startup RevolKa secures $1.4 M funding to advance therapeutic programmes

RevolKa Ltd., a venture-backed biotech company providing a cutting-edge artificial intelligence (AI)-driven protein engi...

May 20, 2025 | Tuesday | News
Collaboration to accelerate genomics innovation in Japan

US-based Illumina, a global leader in DNA sequencing and array-based technologies, and the Okinawa Institute of Science ...

May 16, 2025 | Friday | News
Japan approves Sarepta's gene therapy to treat Duchenne Muscular Dystrophy

US-based Sarepta Therapeutics, Inc. has announced that the Japanese Ministry of Health, Labour, and Welfare (MHLW) has a...

May 14, 2025 | Wednesday | News
Japan's Shionogi inks new partnership agreement to support antimicrobial stewardship in Kenya

Japan headquartered Shionogi & Co. has entered into a comprehensive partnership agreement with Nagasaki University, ...

May 9, 2025 | Friday | News
Japan's Shionogi announces further agreement with Apnimed for sleep disorder treatments

Japan-based Shionogi & Co. has entered into an agreement with US-based Apnimed, Inc. for the introduction of sulthia...

May 5, 2025 | Monday | News
Ken Shinomiya becomes leader of Japan-based Asahi Kasei’s healthcare sector

Asahi Kasei has appointed Ken Shinomiya, President of Asahi Kasei Life Science, as the Leader of its Healthcare Sector s...

May 2, 2025 | Friday | News
Olympus appoints Bob White as new CEO

Japan-based medtech company Olympus Corporation has announced the appointment of a Chief Executive Officer (CEO) aimed a...

April 28, 2025 | Monday | News
Japan's GHIT announces investment of $4.5 M to develop diagnostics for TB

Japan-based Global Health Innovative Technology (GHIT) Fund has announced an investment of approximately JPY 679 mi...

April 23, 2025 | Wednesday | News
Japan's Ono collaborates with Jorna Therapeutics to generate novel RNA editing therapeutics

Japan-based Ono Pharmaceutical has entered into a research collaboration agreement with US-based startup Jorna The...

April 22, 2025 | Tuesday | News
Wayfinder Biosciences and Daiichi Sankyo to develop novel RNA-targeting therapies for neurodegenerative diseases

US-based Wayfinder Biosciences has entered into a collaboration with Japanese pharma firm Daiichi Sankyo to develop RNA-...

April 18, 2025 | Friday | News
Hapatune expands global presence with new life science marketing subsidiary in Tokyo

Hapatune LLC, a leading global marketing boutique for bioprocess and life science tools and service providers, has annou...

April 17, 2025 | Thursday | News
Nikon CeLL Innovation partners with RoosterBio for manufacturing human stem cells and extracellular vesicle in Japan

Nikon CeLL innovation (NCLi), a subsidiary of Japan-based Nikon Corporation has entered into a strategic licensing agree...

April 16, 2025 | Wednesday | News
Saisei Ventures launches executive fellows programme for Japan’s biotech leadership pipeline

Saisei Ventures, a leading venture investment firm focused on advancing Japanese biotechnology and therapeutic innovatio...

April 15, 2025 | Tuesday | News
Japan's PRISM BioLab and Elix join forces to accelerate AI-driven drug discovery

Japan-based PRISM BioLab, a leading discovery and development biotechnology company designing small molecule inhibitors ...

April 14, 2025 | Monday | News
Japan's Asahi Kasei establishes life science unit to drive bioprocess businesses forward

To meet growing demand from the pharmaceutical industry, Japan-based Asahi Kasei has established Asahi Kasei Life Scienc...

April 9, 2025 | Wednesday | News
AGC Biologics taps Thermo Scientific for 5,000 L DynaDrive SUBs at Yokohama site in Japan

AGC Biologics has announced a strategic decision about the large-scale single-use technology it will use at it...

April 8, 2025 | Tuesday | News
Japan's Marubeni buys Sumitomo's Asia pharma biz for ¥45 B

Japan-based Marubeni Corporation has concluded a Share Purchase Agreement with Sumitomo Pharma Co. to acquire shares in ...

April 7, 2025 | Monday | News